Introduction
Hypertension is an important condition affecting overall health, and the prevalence of hypertension is highest in Japan as well as other countries (1) (2) (3) (4) . Chronic high blood pressure (BP) increases the incidence of cardiovascular diseases (CVD) such as stroke, myocardial infarction (5-10), and mortality (11) . Many studies, including randomized controlled trials, have shown that antihypertensive treatment reduces the risk of CVD. However, BP control among hypertensive patients is often insufficient, and a considerable proportion of treated hypertensive patients have not achieved target BP (4, (12) (13) (14) (15) (16) .
Nevertheless, few studies have examined risk factors based on BP categories with or without hypertensive treatment.
Here we examined the association between BP categories and cardiovascular risk factors in a population-based study in Japan.
Methods

Subjects
There were 11,302 subjects in the present study (4,415 men and 6,887 women) for whom information on BP. Data were obtained between April 1992 and July 1995 in 12 districts in rural areas of Japan as part of the Jichi Medical School (JMS) Cohort Study. Details of that project, which was a populationbased prospective cohort study aiming to clarify the risk factors of CVD, were reported elsewhere (17, 18) .
The normotensives were defined as subjects with systolic blood pressure (SBP) < 140 mmHg and diastolic blood pressure (DBP) < 90 mmHg, treated hypertensives were defined as subjects with antihypertensive treatment regardless of current BP, and nontreated hypertensives were defined as subjects with SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg without antihypertensive treatment. Dyslipidemia was defined as total cholesterol ≥ 220 mg/dL and/or triglyceride ≥ 150 mg/dL, and impaired glucose tolerance (IGT) was defined as fasting blood glucose (with no caloric intake for at least 3 h) of ≥ 110 mg/dL, or as casual blood glucose (for less than 3 h or without regard to time since last meal) of 140 mg/dL.
The diagnostic criteria of metabolic syndrome (MS) were decided in Japan in 2005. Although we used these criteria, waist circumference was not measured in most of the subjects, so instead we regard body mass index (BMI) ≥ 25 kg/m 2 as obesity according to the Japanese criteria of obesity. MS was defined by the following criteria: obesity (BMI ≥ 25 kg/ m 2 ) as an essential component combined with two or more of the following components: triglycerides ≥ 150 mg/dL and/or high-densiy lipoprotein (HDL) cholesterol < 40 mg/dL; SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg; fasting blood glucose ≥ 110 mg/dL or casual blood glucose ≥ 140 mg/dL.
The SBP and DBP were measured with a fully automated sphygmomanometer, BP203RV-II (Nippon Colin, Komaki, Japan) placed on the right arm of a seated subject who had rested in the sitting position for 5 min before the measurement. BMI was calculated as weight (kg)/height (m) 2 . Information about medical history and lifestyle was obtained by a questionnaire. Using the Framingham Study questionnaire, physical activity index (PAI) for a normal working day was estimated by calculating the weighted sum of hours spent at five levels: 1.0 for sedation including sleeping, 1.1 for quiet working such as that in a sitting position, 1.5 for a light level of working such as that in a standing position, 2.5 for a moderate level of working, and 5.0 for heavy work (19) .
Total cholesterol and triglyceride were measured by an enzymatic method (Wako, Osaka, Japan; interassay coefficient of variation [CV]: 1.5% for total cholesterol and 1.7% for triglyceride). HDL cholesterol was measured using the phosphotungstate precipitation method (Wako; interassay CV: 1.9%). Blood glucose was measured via an enzymatic method (Kanto Chemistry, Tokyo, Japan; interassay CV: 1.9%).
Lipoprotein(a) (Lp(a)) levels were measured using an enzyme-linked immunosorbent assay (ELIZA) kit (Biopool, Uppsala, Sweden; interassay CV: 3.51%). The minimum detectable Lp(a) level was 1 mg/dL, and undetectable Lp(a) values were recorded as 0.5 mg/dL. Fibrinogen levels were determined with a one-stage clotting assay kit (Data-Fi, Dade Behring, Miami, USA; interassay CV: 2.5%). Factor VII activity was measured with a chromogenic assay using a human placenta-derived calcified thromboplastine reagent (Chromoquick, Behringwerke, Marburg, Germany), human factor VII-deficient plasma (Behringwerke), and a chro- 
Statistical Analysis
Analysis of variance (ANOVA) was used to calculate variance among BP categories, and mean values of lipids, fibrinogen, factor VIIc, BMI, and PAI were shown after age adjustment in each sex. Scheffe's test was used in comparison with the values of variables. The χ 2 test was used for BP categories and other categories such as lipid status, blood glucose status, MS, smoking status, and drinking status, and the Mantel-Haenszel test was used for adjustment for age. These analyses were done using SAS software version 8.2 (SAS Institute, Cary, USA).
Results
The general characteristics of the subjects are shown in Table  1 . The mean ages were 55.2 years in men and 55.3 years in women. SBP and DBP were higher in men (131.4 mmHg and 79.2 mmHg) than in women (128.1 mmHg and 76.3 mmHg).
The proportions of the normotensives, treated hypertensives, and nontreated hypertensives were 62.8%, 10.2%, and 27.0% in men, and 67.1%, 12.5%, and 20.4% in women, respectively (Table 2) .
Age-adjusted mean values of risk factors categorized by BP status were calculated using ANOVA. In both men and women, total cholesterol was lower in normotensives and higher in nontreated hypertensives, whereas triglyceride was lower in normotensives than in treated or nontreated hypertensives. Blood glucose, factor VIIc, and BMI were lower in normotensives than in treated or nontreated hypertensives in both men and women. As for HDL cholesterol, the mean value was higher in normotensives than in treated or nontreated hypertensives in women, but there was no tendency shown in men (Table 3) .
In men, according to Scheffe's test, triglyceride, blood glucose, factor VIIc, BMI, and PAI were significantly higher in treated hypertensives than in normotensives; and total cholesterol, triglyceride, blood glucose, and BMI were significantly higher in nontreated hypertensives than in normotensives. In women, total cholesterol, triglyceride, blood glucose, fibrinogen, factor VIIc, BMI, and PAI were significantly higher in treated hypertensives than in normotensives; and total cholesterol, triglyceride, blood glucose, Lp(a), fibrinogen, factor VIIc, and BMI were significantly higher in nontreated hypertensives than in normotensives ( Table 3) .
Associations of BP categories with lipid status, blood glucose status, MS, smoking status, and drinking status are shown in Table 4 . The proportions of dyslipidemia, IGT, and MS were significantly higher in treated and nontreated hypertensives than in normotensives in men and women using both the χ 2 test and the Mantel-Haenszel test adjusted for age. The same tendency was seen for smoking in men and women. The proportion of drinkers was lower in normotensives than in the treated and nontreated hypertensives in men, whereas in women the proportion of drinkers was lower in hypertensives with treatment than in normotensives and nontreated hypertensives.
Discussion
The JMS Cohort Study (17, 18) , a population-based cardiovascular cohort study using a mass screening examination system, was started in 1992 in a Japanese population. The study subjects were drawn from 12 rural districts in Japan, and the overall response rate was 63%. We examined cardiovascular risk factors in relation to hypertension categories in the present study using baseline data from the JMS Cohort Study.
There may be some bias in this study, such as detection bias, in that a single BP measurement may not reflect actual hypertension, and measurement bias, in that there is not enough information about antihypertensive treatment. Single measurement of BP is substantially considered to underestimate the strength of the relationship between BP and CVD. Single measurement of cholesterol has substantially underestimated the strength of the relationship between cholesterol and the risk of coronary heart disease (20) , and the same framework might be applicable to BP. Single measurement of BP for epidemiological studies may markedly overestimate the true prevalence of hypertension, and a diagnosis of hypertension is difficult (21) . However, in many epidemiological studies, single measurement of BP was used to determine hypertension. Hypertension is an important condition affecting health in Japan as well as in Western countries; hypertension contributes to CVD, such as stroke, ischemic heart diseases, heart failure, and high mortality. In prospective cohorts for the populations, there was a five-fold difference in stroke risk between the highest and lowest of the six BP categories, but relative stroke risks were greater in middle age than in old age even though absolute stroke risks were higher in old age (8) . In other cohorts for a population in East Asia, BP was an important determinant of stroke risk, whereas cholesterol concentration was less important. The authors concluded that the association between BP and stroke seems stronger in East Asia than in Western populations, and a population-wide reduction of 3 mmHg in DBP eventually decreased the number of strokes by about one-third (22) .
In case-control studies for the incidence of stroke in hypertensive patients, higher levels of BP were related to the onset of stroke (7, 23, 24) and myocardial infarction (6) , and a considerable proportion of the stroke incidence among treated hypertensive patients may be prevented by achieving BP control (7). Bulpitt et al. reported that the optimal level of BP control for survival was treated SBP of < 134 mmHg in men and < 149 mmHg in women, and treated DBP of < 95 mmHg in men and women in a prospective cohort study in hypertensive patients (11) .
Many intervention trials have proven that antihypertensive drugs will help reduce the incidence of CVD. In a meta-analysis, the effect of antihypertensive drugs was significant for stroke and CVD in men and women; and, in terms of relative risk, the treatment benefit did not differ between men and women (25) (26) (27) . Meanwhile, arterial stiffness increased with age according to the severity of hypertension, after adjustment for BP (28) .
Even if hypertensive patients receive antihypertensive treatment, such treatment seems less effective if it does not achieve the target BP, for example 140/90 mmHg. In the present study, actually, elevation in treated hypertensives was seen in some cardiovascular risk factors, such as total cholesterol, blood glucose, fibrinogen, BMI, and PAI, in comparison with normotensives. Antihypertensive treatment does not modify the patient's physical condition and does not reduce BMI. A similar analysis of blood glucose in Japanese patients was performed in a previous study, and serum insulin and BMI were also higher in treated hypertensives than in normotensives, although hypertension was defined by SBP ≥ 160 mmHg and/or DBP ≥ 95 mmHg (1).
We found a different tendency between men and women with regard to HDL cholesterol. Although HDL was known to be affected by drinking alcohol (29, 30) , the results was identical after adjustment for age and alcohol drinking status. Higher HDL cholesterol in normotensives in women was due to a lower BMI level. That was because the difference in HDL cholesterol in women was not detected after adjustment for BMI in addition to age and drinking status. Yamamoto et al. reported that low HDL was related to high triglycerides and BMI in large-scale cross-sectional data, and this tendency was similar to ours (31) . Serum insulin was higher in hypertensives with or without treatment in our data (data not shown because of the smaller number of subjects). Of course, lowering BP reduces the incidence of CVD, but it is more important to control BP or modify lifestyle. In a clinical setting, home BP has been used to evaluate BP control in recent years, but even now, neither home nor office BP values are adequately controlled (32) . 2 as an essential combined with 2 or more of the following components: triglycerides ≥150 mg/dL and/or HDL cholesterol <40 mg/dL; systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg; fasting blood glucose ≥110 mg/dL. IGT, impaired glucose tolerance; MS, metabolic syndrome; BMI, body mass index; HDL, high-density lipoprotein.
We examined metabolic profiles such as dyslipidemia and IGT in relation to the different BP categories. In recent years it has been proposed that hypertension is part of a cluster of metabolic risk factors and is such as MS (33) , and that MS is related to other CVD risk factors and manifestations, such as pulse wave velocity and sleep apnea syndrome (34) (35) (36) (37) . The Japanese criteria for MS were applied using BMI ≥ 25 kg/m 2 to define obesity in the present study, because waist circumference was not measured in most of the subjects. The proportion of hypertensive subjects with MS was also higher than that of normotensives with this syndrome. Even if we could have controlled BP, we could not control all other risk factors for CVD. Shapo et al. reported results similar to ours, i.e., higher levels of total cholesterol, triglycerides, and glucose tolerance in hypertensives with or without medication than in normotensives, and higher levels in untreated than treated hypertensives. In our study, after adjustment for age, the findings were identical (13) . In other studies, two-thirds of the hypertensive population were aware of the diagnosis, but only a quarter of the hypertensives were adequately controlled (4, 14, 16) . Our data showed a similar tendency.
We thought a limitation of the present study was that only the relationship between BP categories and cardiovascular risk factors was investigated, and not the relationships between BP categories and CVD as true outcomes. We have been conducting a follow-up study for stroke and myocardial infarction, and some data will be shown in the future.
